Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.

Heidemeyer, Kristine; May Lee, Marco; Cazzaniga, Simone; Yawalkar, Nikhil; Naldi, Luigi (2023). Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies. Psoriasis - targets and therapy, 13, pp. 33-58. Dove Medical Press 10.2147/PTT.S400402

[img]
Preview
Text
PTT-400402-palmoplantar-pustulosis--a-systematic-review-of-risk-factors.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (2MB) | Preview

Palmoplantar pustulosis (PPP) is a chronic, relapsing, inflammatory disease that can occur alone or in association with arthritis. There is still controversy about whether it should be separated from psoriasis or classified as pustular psoriasis. Furthermore, drug-induced paradoxical PPP is a special variant of PPP that differs from classic PPP in several ways. Treatment of PPP is still challenging, and there are a number of treatment-resistant cases. This review summarizes the risk factors for the development of PPP and the currently available treatment modalities. Female sex, smokers or ex-smokers, obesity, thyroid dysfunction, and treatment with a tumor necrosis factor (TNF)-α inhibitor have been identified as risk factors for the disease's development, severity, and course. Topical treatments and phototherapy are effective for some patients and are used as a first-line or adjuvant treatment modality. Conventional treatments including retinoids and fumaric acid show good effects and can increase the efficacy of treatment with psoralen + ultraviolet light therapy (PUVA). Ciclosporin is fast acting, but relapse mostly occurs immediately after cessation. TNF-α inhibitors are efficient, and an even better response can be achieved with IL-17 and IL-23 blockers as well as apremilast. The effect of Janus kinase inhibitors seems to be promising according to case reports, but further investigations with larger cohorts are needed.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Heidemeyer, Kristine, Cazzaniga, Simone, Yawalkar, Nikhil, Naldi, Luigi

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2230-326X

Publisher:

Dove Medical Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

03 Oct 2023 09:25

Last Modified:

04 Oct 2023 06:11

Publisher DOI:

10.2147/PTT.S400402

PubMed ID:

37772169

Uncontrolled Keywords:

palmoplantar psoriasis pustulosis risk factors treatment

BORIS DOI:

10.48350/186798

URI:

https://boris.unibe.ch/id/eprint/186798

Actions (login required)

Edit item Edit item
Provide Feedback